Gate Diagnostics is proud to announce that the company has been granted its first European patent covering its core diagnostic technology platform.

Gate Diagnostics is excited to announce its first-time attendance at the Ocala Equine Conference this February, where the company will highlight Sequre™, its rapid molecular testing platform for equine respiratory disease. Hosted at the Equestrian Manor on the grounds of the World Equestrian Center, the Ocala Equine Conference brings together a highly targeted audience of Florida-based equine veterinarians, providing a focused setting for meaningful technical and clinical discussions.

Gate Diagnostics is excited to announce its upcoming attendance at the 2025 American Association of Equine Practitioners (AAEP) Annual Convention, taking place December 7–11, where the company will officially introduce Sequre™, its rapid molecular testing platform for equine respiratory disease.

Gate Diagnostics is excited to announce our participation in the upcoming American Association of Equine Practitioners (AAEP) Annual Convention, where we will unveil our cutting-edge diagnostic platform, Sequre, to equine veterinarians from across the country.

Gate Diagnostics is thrilled to announce that we will be attending the International Equine Infectious Disease Conference (IEIDC)!